198 related articles for article (PubMed ID: 30848917)
1. Topography of Simulated Intestinal Equilibrium Solubility.
Dunn C; Perrier J; Khadra I; Wilson CG; Halbert GW
Mol Pharm; 2019 May; 16(5):1890-1905. PubMed ID: 30848917
[TBL] [Abstract][Full Text] [Related]
2. Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design.
Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert GW
Mol Pharm; 2017 Dec; 14(12):4132-4144. PubMed ID: 28749696
[TBL] [Abstract][Full Text] [Related]
3. Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs.
Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert GW
Eur J Pharm Sci; 2017 Mar; 99():95-104. PubMed ID: 27940083
[TBL] [Abstract][Full Text] [Related]
4. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
McPherson S; Perrier J; Dunn C; Khadra I; Davidson S; Ainousah B; Wilson CG; Halbert G
Eur J Pharm Biopharm; 2020 May; 150():14-23. PubMed ID: 32035969
[TBL] [Abstract][Full Text] [Related]
5. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs.
Khadra I; Zhou Z; Dunn C; Wilson CG; Halbert G
Eur J Pharm Sci; 2015 Jan; 67():65-75. PubMed ID: 25444845
[TBL] [Abstract][Full Text] [Related]
6. Statistical investigation of the full concentration range of fasted and fed simulated intestinal fluid on the equilibrium solubility of oral drugs.
Perrier J; Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert G
Eur J Pharm Sci; 2018 Jan; 111():247-256. PubMed ID: 28987539
[TBL] [Abstract][Full Text] [Related]
7. Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments.
Madsen CM; Feng KI; Leithead A; Canfield N; Jørgensen SA; Müllertz A; Rades T
Eur J Pharm Sci; 2018 Jan; 111():311-319. PubMed ID: 28986196
[TBL] [Abstract][Full Text] [Related]
8. Dual Level Statistical Investigation of Equilibrium Solubility in Simulated Fasted and Fed Intestinal Fluid.
Ainousah BE; Perrier J; Dunn C; Khadra I; Wilson CG; Halbert G
Mol Pharm; 2017 Dec; 14(12):4170-4180. PubMed ID: 29072917
[TBL] [Abstract][Full Text] [Related]
9. Multidimensional analysis of human intestinal fluid composition.
Pyper K; Brouwers J; Augustijns P; Khadra I; Dunn C; Wilson CG; Halbert GW
Eur J Pharm Biopharm; 2020 Aug; 153():226-240. PubMed ID: 32585351
[TBL] [Abstract][Full Text] [Related]
10. Structured solubility behaviour in fed simulated intestinal fluids.
Silva MI; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2023 Dec; 193():58-73. PubMed ID: 37890541
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids.
Henze LJ; Koehl NJ; Jansen R; Holm R; Vertzoni M; Whitfield PD; Griffin BT
Eur J Pharm Biopharm; 2020 Sep; 154():116-126. PubMed ID: 32580049
[TBL] [Abstract][Full Text] [Related]
12. Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids.
Söderlind E; Karlsson E; Carlsson A; Kong R; Lenz A; Lindborg S; Sheng JJ
Mol Pharm; 2010 Oct; 7(5):1498-507. PubMed ID: 20698569
[TBL] [Abstract][Full Text] [Related]
13. Fasted intestinal solubility limits and distributions applied to the biopharmaceutics and developability classification systems.
Abuhassan Q; Khadra I; Pyper K; Augustijns P; Brouwers J; Halbert GW
Eur J Pharm Biopharm; 2022 Jan; 170():160-169. PubMed ID: 34923138
[TBL] [Abstract][Full Text] [Related]
14. Effect of Surfactant-Bile Interactions on the Solubility of Hydrophobic Drugs in Biorelevant Dissolution Media.
Vinarov Z; Katev V; Burdzhiev N; Tcholakova S; Denkov N
Mol Pharm; 2018 Dec; 15(12):5741-5753. PubMed ID: 30351956
[TBL] [Abstract][Full Text] [Related]
15. Structured solubility behaviour in bioequivalent fasted simulated intestinal fluids.
Abuhassan Q; Khadra I; Pyper K; Augustijns P; Brouwers J; Halbert GW
Eur J Pharm Biopharm; 2022 Jul; 176():108-121. PubMed ID: 35605926
[TBL] [Abstract][Full Text] [Related]
16. Impact of phospholipid digests and bile acid pool variations on the crystallization of atazanavir from supersaturated solutions.
Enright EF; Joyce SA; Gahan CGM; Taylor LS
Eur J Pharm Biopharm; 2020 Aug; 153():68-83. PubMed ID: 32473291
[TBL] [Abstract][Full Text] [Related]
17. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
Mohsin K
AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
[TBL] [Abstract][Full Text] [Related]
18. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
Dahlgren D; Venczel M; Ridoux JP; Skjöld C; Müllertz A; Holm R; Augustijns P; Hellström PM; Lennernäs H
Eur J Pharm Biopharm; 2021 Jun; 163():240-251. PubMed ID: 33872761
[TBL] [Abstract][Full Text] [Related]
19. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
Fagerberg JH; Tsinman O; Sun N; Tsinman K; Avdeef A; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1419-30. PubMed ID: 20507160
[TBL] [Abstract][Full Text] [Related]
20. Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid.
Abuhassan Q; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2021 Nov; 168():90-96. PubMed ID: 34419602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
